Statement Of Cash Flows	7 Months Ended
	Dec. 31, 2021 USD ($)
Cash flows from operating activities:
Net loss	$ (84,624,724)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative liabilities	29,275,740
Financing expense on derivative liabilities	54,956,475
Interest on marketable securities held in Trust Account	(5,954)
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	32,419
Prepaid expenses	(1,502,156)
Net cash used in operating activities	(1,868,200)
Cash flows from investing activities:
Investment of cash into Trust Account	(287,500,000)
Net cash used in investing activities	(287,500,000)
Cash flows from Financing activities:
Proceeds from initial public offering, net of costs	281,750,000
Proceeds from Private Placement Shares	9,750,000
Proceeds from issuance of promissory payable - related party	226,376
Payment of promissory note payable - related party	(300,000)
Payments of deferred offering costs included in accrued expenses	(798,737)
Net cash provided by financing activities	290,627,639
Net change in cash	1,259,439
Cash, beginning of the period
Cash, end of the period	1,259,439
Supplemental disclosure of noncash financing activities:
Deferred underwriters fee charged to additional paid in capital	$ 10,062,500